IRIS
CIURLEO, ROSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.106
EU - Europa 2.878
AS - Asia 1.471
SA - Sud America 476
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 35
OC - Oceania 1
Totale 12.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.037
RU - Federazione Russa 1.601
SG - Singapore 554
CN - Cina 461
BR - Brasile 399
SE - Svezia 329
IE - Irlanda 315
HK - Hong Kong 168
IT - Italia 127
DE - Germania 126
VN - Vietnam 110
UA - Ucraina 106
FR - Francia 77
FI - Finlandia 62
GB - Regno Unito 53
IN - India 42
CA - Canada 32
AR - Argentina 25
BD - Bangladesh 24
MX - Messico 22
AT - Austria 16
TR - Turchia 15
PL - Polonia 14
IQ - Iraq 13
CO - Colombia 12
JP - Giappone 12
NL - Olanda 11
BE - Belgio 9
EC - Ecuador 9
VE - Venezuela 9
PK - Pakistan 8
ZA - Sudafrica 8
MA - Marocco 7
PY - Paraguay 7
UY - Uruguay 7
UZ - Uzbekistan 7
JO - Giordania 6
TN - Tunisia 6
ID - Indonesia 5
IL - Israele 5
CI - Costa d'Avorio 4
ES - Italia 4
HN - Honduras 4
JM - Giamaica 4
KE - Kenya 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KR - Corea 3
PH - Filippine 3
PT - Portogallo 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
VC - Saint Vincent e Grenadine 1
Totale 11.970
Salva come PNG Salva come JPEG
Città #
Dallas 4.689
Moscow 454
Ashburn 415
Dublin 315
Chandler 306
Singapore 274
Nyköping 215
Jacksonville 192
Hong Kong 165
Beijing 139
San Jose 133
Council Bluffs 93
Dearborn 87
The Dalles 66
New York 59
Princeton 54
Dong Ket 52
Lauterbourg 52
Los Angeles 52
Medford 48
Cambridge 46
Boardman 43
Des Moines 41
Messina 33
Munich 31
Buffalo 26
São Paulo 24
Jinan 21
Ho Chi Minh City 20
Santa Clara 19
Ann Arbor 18
Hebei 17
Nanjing 17
Redondo Beach 17
Tianjin 15
Guangzhou 14
Rio de Janeiro 14
Chennai 13
Milan 13
Vienna 13
Columbus 12
Frankfurt am Main 12
Orem 12
Tokyo 12
Wilmington 12
Woodbridge 12
Bremen 11
Warsaw 11
Belo Horizonte 10
Taiyuan 10
Turku 10
Brussels 9
Curitiba 9
Phoenix 9
Brooklyn 8
Hanoi 8
Hyderabad 8
London 8
Seattle 8
Washington 8
Boston 7
Campinas 7
Catania 7
Lancaster 7
Montreal 7
Shanghai 7
Taizhou 7
Tashkent 7
Toronto 7
Brasília 6
Changsha 6
Chicago 6
Montevideo 6
Montréal 6
Salvador 6
Shenyang 6
Shenzhen 6
Stockholm 6
Amman 5
Amsterdam 5
Asunción 5
Atlanta 5
Baghdad 5
Contagem 5
Dhaka 5
Helsinki 5
Houston 5
Johannesburg 5
Joinville 5
Nanchang 5
Piracicaba 5
Poplar 5
Abidjan 4
Da Nang 4
Denver 4
Fuzhou 4
Haikou 4
Hefei 4
Istanbul 4
Lappeenranta 4
Totale 8.733
Salva come PNG Salva come JPEG
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 4.793
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 213
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 210
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 207
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 195
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 191
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 190
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 185
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 179
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 178
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 177
Functional evaluation of awareness in vegetative and minimally conscious state 174
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 169
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 165
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 159
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 154
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 151
Functional connectivity in vegetative state patients 150
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 145
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 143
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 142
White matter substrates of functional connectivity dynamics in the human brain 141
Neurophysiological approach in comatose patients 141
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 139
The role of brain oscillations in post-stroke motor recovery: an overview 135
Evaluation of olfactory dysfunction in neurodegenerative diseases 132
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 132
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 128
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 126
Reality orientation therapy (ROT) in Alzheimer’s disease. 119
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 118
Neurogenic ejaculatory disorders: focus on current and future treatments. 112
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 111
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 108
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 105
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 101
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 100
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 98
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 97
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 95
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 92
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 90
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 90
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 88
The clinical use of quality of life scales in the neurodegenerative diseases 88
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 86
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 86
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 84
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 83
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 82
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 82
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 79
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 79
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 74
Role of statins in the treatment of multiple sclerosis 72
Identification of common pathogenetic processes between schizophrenia and diabetes mellitus by systems biology analysis 69
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 69
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 43
null 37
Neuroanatomical correlates of peripersonal space: bridging the gap between perception, action, emotion and social cognition 35
Totale 12.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022292 0 0 4 6 29 1 53 6 8 14 46 125
2022/20231.087 92 110 43 95 89 122 26 55 408 8 28 11
2023/2024301 19 44 21 34 29 92 1 20 2 14 6 19
2024/20251.170 7 15 38 65 46 23 31 259 323 84 89 190
2025/20268.029 133 1.491 3.392 322 323 804 357 467 453 153 76 58
2026/2027183 61 109 13 0 0 0 0 0 0 0 0 0
Totale 12.016